Clinical Trial: Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07125755) titled 'Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma' on Aug. 10.

Brief Summary: The main objective of this trial was to determine the value of concurrent chemoradiotherapy for Intermediate-risk head and neck squamous cell carcinoma

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: Squamous Cell Cancer of Head and Neck (SCCHN)

Intervention: DRUG: Cisplatin

Concurrent Cisplatin chemotherapy (100 mg/m2 intravenous injection,once every 3 weeks, twice in total, on days 1 and 22) will be given plus intensit...